微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 81.05% | -8.32% | 7.46% | 14/54 | 69.26% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 75.43% | -25.34% | -16.24% | 21/54 | 68.54% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 90.05% | -10.15% | 2.23% | 7/54 | 69.17% | 康华生物 | 95.85% | 行业排名> |
| 2023-12-31 | 88.09% | 0% | -0.37% | 10/54 | 68.33% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 88.41% | 0.57% | -12.48% | 10/54 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 101.02% | 14.22% | 0.8% | 1/54 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 100.22% | 1.86% | 13.77% | 1/54 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 88.09% | 0.17% | 0.2% | 9/54 | 68.27% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 87.91% | -0.42% | -0.6% | 13/54 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 88.44% | -3.03% | -10.11% | 13/54 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 98.39% | 2% | 11.89% | 1/54 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 87.94% | -1.6% | -0.39% | 15/54 | 72.33% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 88.28% | 2% | -3.21% | 15/54 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 91.21% | -87.11% | 2.06% | 6/54 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2020-12-31 | 89.37% | 5.57% | -87.37% | 12/54 | 71.61% | 义翘神州 | 96.83% | 行业排名> |
| 2020-06-30 | 707.43% | 2% | 735.69% | 1/54 | 88.2% | 义翘神州 | 96.88% | 行业排名> |
| 2019-12-31 | 84.65% | 0.54% | 0.54% | 21/54 | 72.44% | 义翘神州 | 96.56% | 行业排名> |
| 2018-12-31 | 84.2% | 21.73% | 21.73% | 18/54 | 71.54% | 华兰疫苗 | 707.43% | 行业排名> |
| 2017-12-31 | 69.16% | 2% | 2% | 24/54 | -887.82% | 我武生物 | 95.6% | 行业排名> |